2014
DOI: 10.1002/ajhb.22671
|View full text |Cite
|
Sign up to set email alerts
|

GSTM1, GSTP1, and GSTT1 genetic variability in Turkish and worldwide populations

Abstract: This study provides novel data about GSTM1 positive/null, GSTT1 positive/null, GSTP1*I105V, and GSTP1*A114V variants in the Turkish population, and other functional variants that may affect GSTM1, GSTT1, and GSTP1 functions among worldwide populations. This information can assist in the design of future genetic association studies investigating oxidative stress-related diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(11 citation statements)
references
References 48 publications
(50 reference statements)
1
10
0
Order By: Relevance
“…The present study revealed that the frequency of GSTT1 null genotype is (20.4%), this frequency is higher than those reported in a previous case control study that was performed by Al-Awadiy et al (22) in the Iraqi population, which was (6.9%). The GSTT1 null genotype frequency was similar to Caucasian (19.7%) and concordant with those documented for Turkish (23%) population and was lower than that reported in Arab (37.1%) and African (26%) population (25,30) (table 1). The GSTM1 null genotype frequency (66.2%) reported in the current study was comparable to that observed in Asians and Caucasians (40-62%) (23) but higher than that observed in African (26.7%) The proportion of double nulls (GSTM1 and GSTT1 null genotypes), synonymous of absence of enzyme activity in the sample study (12%) was concordant to that previously reported by Al-Awadi et al (22) for the Iraqi population(10%) as well as for other Arab populations, including Bahraini (14.4%); Lebanese (16.3%) population; and it is nearly similar to that of the Caucasians and African population and less than that observed in Arabs (Saudi) population (24,25) .…”
Section: Discussionsupporting
confidence: 88%
“…The present study revealed that the frequency of GSTT1 null genotype is (20.4%), this frequency is higher than those reported in a previous case control study that was performed by Al-Awadiy et al (22) in the Iraqi population, which was (6.9%). The GSTT1 null genotype frequency was similar to Caucasian (19.7%) and concordant with those documented for Turkish (23%) population and was lower than that reported in Arab (37.1%) and African (26%) population (25,30) (table 1). The GSTM1 null genotype frequency (66.2%) reported in the current study was comparable to that observed in Asians and Caucasians (40-62%) (23) but higher than that observed in African (26.7%) The proportion of double nulls (GSTM1 and GSTT1 null genotypes), synonymous of absence of enzyme activity in the sample study (12%) was concordant to that previously reported by Al-Awadi et al (22) for the Iraqi population(10%) as well as for other Arab populations, including Bahraini (14.4%); Lebanese (16.3%) population; and it is nearly similar to that of the Caucasians and African population and less than that observed in Arabs (Saudi) population (24,25) .…”
Section: Discussionsupporting
confidence: 88%
“…The results in our control population were similar to those that are found in Caucasians and the Turkish population that were found in other studies. In a recent study that was performed in the Turkish population, by Karaca et al (2015) , it was reported that the frequencies of the null genotype of the GSTM1 and the GSTT1 genes were 52% and 23%, respectively, and the frequency of the Val105 allele of the GSTP1 was 29%.…”
Section: Discussionmentioning
confidence: 99%
“…All laboratory procedures were performed according to the manufacturer's protocol of the MassArray platform (Sequenom Inc., CA, USA). Detailed information about the genotyping pipeline is reported in our previous study [22].…”
Section: Genotypingmentioning
confidence: 99%
“…The genetic background of the Turkish population is an admixture of European, Middle Eastern and Central Asian ancestries [21]. Although Turkish people share a relevant percentage of their genetic background with Europeans, significant differences are present between Turkish and North European populations, partially explaining the health disparities of Turkish communities in Northern Europe [22,23]. To our knowledge, three previous studies investigated the impact of VKORC1 and CYP2C9 polymorphisms on warfarin dosing in the Turkish populations [24][25][26].…”
Section: Introductionmentioning
confidence: 96%